home / stock / vygr / vygr quote
Last: | $7.42 |
---|---|
Change Percent: | 2.51% |
Open: | $7.38 |
Close: | $7.42 |
High: | $7.52 |
Low: | $7.26 |
Volume: | 522,452 |
Last Trade Date Time: | 04/25/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$7.42 | $7.38 | $7.42 | $7.52 | $7.26 | 522,452 | 04-25-2024 |
$7.57 | $7.65 | $7.57 | $7.66 | $7.45 | 312,783 | 04-24-2024 |
$7.65 | $7.6 | $7.65 | $7.78 | $7.57 | 372,354 | 04-23-2024 |
$7.57 | $7.56 | $7.57 | $7.7 | $7.47 | 324,119 | 04-22-2024 |
$7.5 | $7.5 | $7.5 | $7.66 | $7.2831 | 516,459 | 04-19-2024 |
$7.55 | $7.74 | $7.55 | $7.88 | $7.51 | 1,015,265 | 04-18-2024 |
$7.74 | $8.04 | $7.74 | $8.04 | $7.7 | 785,424 | 04-17-2024 |
$7.98 | $8.38 | $7.98 | $8.4 | $7.95 | 398,336 | 04-16-2024 |
$8.24 | $8.36 | $8.24 | $8.4535 | $8.125 | 450,425 | 04-15-2024 |
$8.43 | $8.73 | $8.43 | $8.84 | $8.39 | 565,057 | 04-12-2024 |
$8.78 | $8.9 | $8.78 | $9.02 | $8.75 | 426,084 | 04-11-2024 |
$8.83 | $8.9 | $8.83 | $8.97 | $8.7 | 528,696 | 04-10-2024 |
$9.09 | $9.09 | $9.09 | $9.24 | $9 | 307,834 | 04-09-2024 |
$9.06 | $9.41 | $9.06 | $9.41 | $9.02 | 347,615 | 04-08-2024 |
$9.33 | $9.15 | $9.33 | $9.34 | $8.97 | 481,497 | 04-05-2024 |
$9.13 | $9.4 | $9.13 | $9.66 | $9.12 | 688,007 | 04-04-2024 |
$9.35 | $9.63 | $9.35 | $9.72 | $9.25 | 793,731 | 04-03-2024 |
$9.91 | $10.31 | $9.91 | $10.31 | $9.68 | 723,500 | 04-02-2024 |
$10.54 | $9.56 | $10.54 | $10.66 | $9.43 | 1,400,289 | 04-01-2024 |
$9.31 | $9.58 | $9.31 | $9.676 | $9.2 | 629,050 | 03-29-2024 |
News, Short Squeeze, Breakout and More Instantly...
Voyager Therapeutics Inc. Company Name:
VYGR Stock Symbol:
NASDAQ Market:
Voyager Therapeutics Inc. Website:
LEXINGTON, Mass., April 22, 2024 (GLOBE NEWSWIRE) -- Voyager Therapeutics, Inc. (NASDAQ:VYGR), a biotechnology company dedicated to advancing ne...
LEXINGTON, Mass., April 22, 2024 (GLOBE NEWSWIRE) -- Voyager Therapeutics, Inc. (Nasdaq: VYGR), a biotechnology company dedicated to advancing neurogenetic medicines, today announced that it will present a broad set of data related to its TRACER™ capsid discovery platform and TRACER-driven...
LEXINGTON, Mass., April 16, 2024 (GLOBE NEWSWIRE) -- Voyager Therapeutics, Inc. (Nasdaq: VYGR), a biotechnology company dedicated to advancing neurogenetic medicines, today announced that the joint steering committee with its collaborator Neurocrine Biosciences has selected a lead development can...